Echo lake capital increase offer to acquire quince therapeutics, inc.

Offers $1.80 per share in cash plus cvr to receive 85% of the future net proceeds quince receives as part of the lighthouse pharmaceuticals transaction stock trades below its net cash and investments balance of approximately $2.30 per share willing to increase cash component of the offer if company can demonstrate that its net cash at closing would be higher than we currently estimate offer's cash component alone represents 115% premium to company's stock price before our original buyout offer in march new york, ny / accesswire / july 13, 2023 / earlier today echo lake capital issued a letter to the board of directors of quince therapeutics, inc. (nasdaq:qncx). the letter described a revised proposal to acquire all the company's common stock for $1.80 per share in cash plus a cvr to receive 85% of the future net proceeds received from the lighthouse pharmaceutical transaction announced on january 27, 2023.
QNCX Ratings Summary
QNCX Quant Ranking